Jennifer Butler

Jennifer Butler

Alston & Bird

Contact
View Bio
RSS

Latest Posts › HRSA

Share:

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

1/7/2019  /  ACOs , Centers for Medicare & Medicaid Services (CMS) , Fee-for-Service , HRSA , Medicare , SAMHSA

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

12/24/2018  /  ACOs , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Fee-for-Service , Food and Drug Administration (FDA) , HRSA , Medicare , Opioid , Prescription Drugs , SAMHSA

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

12/17/2018  /  Biosimilars , BPCIA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , OCR

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

12/3/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medicare , Medicare Part D , PDUFA

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

11/5/2018  /  ACOs , Ambulatory Surgery Centers , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , Medicare Part B , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs , Section 340B

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

9/10/2018  /  Centers for Disease Control and Prevention (CDC) , Draft Guidance , Food and Drug Administration (FDA) , GAO , HRSA , MedPAC , Opioid

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

9/4/2018  /  Department of Veterans Affairs , Food and Drug Administration (FDA) , HRSA , Opioid , Pharmaceutical Industry , Prescription Drugs , Veterans

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

8/27/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , Healthcare Fraud , HRSA , Inpatient Prospective Payment System (IPPS) , Medicare , OIG

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

7/2/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Opioid , Pharmaceutical Industry , Physicians , Prescription Drugs , Section 340B

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

6/4/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Prescription Drugs , Section 340B

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

5/21/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Generic Drugs , HRSA , Institutional Review Board (IRB) , Pharmaceutical Industry , Section 340B

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

4/16/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Essential Health Benefits , Food and Drug Administration (FDA) , HRSA , Qualified Health Plans

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

4/9/2018  /  Abbreviated New Drug Application (ANDA) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Generic Drugs , HCPCS , HRSA , Medicare Advantage , Medicare Part A , Medicare Part D , Pharmaceutical Industry

Alston & Bird Healthcare Week In Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

3/19/2018  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HCPCS , Health Care Providers , HRSA , Medical Devices

Alston & Bird Healthcare Week In Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

3/12/2018  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HCPCS , Health Care Providers , HRSA , SAMHSA

Alston & Bird Healthcare Week In Review

I. Regulations, Notices, & Guidance - On February 26, 2018, the Food and Drug Administration (FDA) issued a final order entitled, Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test....more

3/5/2018  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Medical Devices , Medicare , Prescription Drugs

Alston & Bird Healthcare Week In Review

I. Regulations, Notices, & Guidance - On February 12, 2018, the Food and Drug Administration (FDA) issued a guidance entitled, Bacillus Calmette-Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs and...more

2/20/2018  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , HRSA , Inpatient Prospective Payment System (IPPS) , OIG , SAMHSA

Alston & Bird Healthcare Week In Review

I. Regulations, Notices, & Guidance - On February 5, 2018, the Drug Enforcement Agency (DEA) issued a temporary scheduling order entitled, Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related...more

2/12/2018  /  Abbreviated New Drug Application (ANDA) , Controlled Substances Act , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HRSA , Inpatient Prospective Payment System (IPPS) , OMB , SAMHSA

Alston & Bird Healthcare Week In Review

On January 22, 2018, the Drug Enforcement Administration (DEA) issued a final rule entitled, Implementation of the Provision of the Comprehensive Addiction and Recovery Act of 2016 Relating to the Dispensing of Narcotic Drugs...more

1/29/2018  /  Centers for Medicare & Medicaid Services (CMS) , CLIA , Clinical Laboratories , Comprehensive Addiction and Recovery Act of 2016 (CARA) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HELP , HRSA , Inpatient Prospective Payment System (IPPS) , Opioid , REMS , SAMHSA

Alston & Bird Healthcare Week In Review

On January 16, 2018, the Food and Drug Administration (FDA) issued a proposed rule entitled, Internal Agency Review of Decisions; Requests for Supervisory Review of Certain Decisions Made by the Center for Devices and...more

1/23/2018  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Inpatient Prospective Payment System (IPPS) , Medicare , OCR , REMS , SAMHSA

Alston & Bird Healthcare Week in Review

On November 27, 2017, the Food and Drug Administration (FDA) issued a guidance entitled, Pediatric Information for X-ray imaging Device Premarket Notifications. The guidance outlines FDA’s rationale regarding information that...more

12/6/2017  /  21st Century Cures Act , Centers for Medicare & Medicaid Services (CMS) , CLIA , Department of Health and Human Services (HHS) , Episode Payment Models (EPM) , Food and Drug Administration (FDA) , Health Care Providers , HELP , HRSA , Inpatient Prospective Payment System (IPPS)

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 21, 2016, CMS issued a proposed rule entitled, “Medicare Program: FY 2017 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements.” This...more

4/28/2016  /  1099s , Affordable Care Act , Biologics , Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , HCPCS , Health Care Providers , Health Savings Accounts , Hospice , HRSA , Inpatient Prospective Payment System (IPPS) , Inpatient Quality Reporting , Inpatient Rehab Facilities , IRS , Legislative Agendas , Long Term Care Facilities , Medicaid , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Medicare Part B , OIG , Opioid , Physician Medicare Reimbursements , Prescription Drugs , SAMHSA , Section 340B , Skilled Nursing Facility , Traumatic Brain Injuries , Veterans

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 15, 2016, the Food and Drug Administration (FDA) issued a proposed rule entitled, “Applications for Approval and Combinations of Active Ingredients Under Consideration for...more

4/21/2016  /  Abbreviated New Drug Application (ANDA) , Affordable Care Act , AHRQ , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , CGMP , Department of Health and Human Services (HHS) , DSCSA , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , HRSA , IRS , Legislative Agendas , Medicaid , Medical Devices , Medicare , OIG , Overpayment , Pharmaceutical Industry , Prescription Drugs , Public Health Insurance Marketplace , Tax Liability

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 4, 2016, the Centers for Medicare & Medicaid Services (CMS) issued the Final Calendar Year (CY) 2017 Medicare Advantage Capitation Rates and Medicare Advantage (MA) and...more

4/8/2016  /  Affordable Care Act , Biologics , Cancer , Centers for Medicare & Medicaid Services (CMS) , Department of Veterans Affairs , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Legislative Agendas , Medicaid , Medical Devices , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Medicare Advantage , Medicare Part D , OIG , OMB , Organ Donation , Over The Counter Derivatives (OTC) , Prescription Drugs , Qualified Health Plans , SAMHSA , Vaccinations , Veterans

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On March 29, 2016, Centers for Medicare & Medicaid Services (CMS) issued a final rule entitled, “Medicaid and Children’s Health Insurance Programs: Mental Health Parity and...more

4/1/2016  /  Affordable Care Act , AHRQ , Americans with Disabilities Act (ADA) , Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Controlled Substances Act , Cost-Sharing , Department of Health and Human Services (HHS) , Equal Employment Opportunity Commission (EEOC) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Labeling , Legislative Agendas , Medicaid , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Mental Health , MIPS , OMB , Prescription Drugs , SAMHSA , Substance Abuse , Title I , Vaccinations , Wellness Programs
27 Results
 / 
View per page
Page: of 2
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide